Showing results (111-120 of 2,117) with videos related to
Sort By:
Pageof 212
International Clinical Psychopharmacology|March 1, 1997
Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerabilityA Puech, S A Montgomery, J F Prost, et al.International Clinical Psychopharmacology|January 1, 1994
Tolerability of combined treatment with lithium and fluoxetine: 14 cases treated under open conditionsC J Hawley, A G Roberts, D S BaldwinInternational Clinical Psychopharmacology|January 1, 1994
Adverse experiences during treatment with zimeldine on special licence in SwedenB O Bengtsson, B E Wiholm, M Myrhed, et al.International Clinical Psychopharmacology|May 1, 1997
A double-blind comparative study of clozapine versus chlorpromazine on Chinese patients with treatment-refractory schizophreniaC J Hong, J Y Chen, H J Chiu, et al.International Clinical Psychopharmacology|May 1, 1997
An open-label study of duloxetine hydrochloride, a mixed serotonin and noradrenaline reuptake inhibitor, in patients with DSM-III-R major depressive disorder. Lilly Duloxetine Depression Study GroupM Berk, A D du Plessis, M Birkett, et al.International Clinical Psychopharmacology|May 1, 1997
Lack of effect of amitriptyline on risperidone pharmacokinetics in schizophrenic patientsD K Sommers, J R Snyman, M van Wyk, et al.International Clinical Psychopharmacology|May 1, 1997
Relationship between single oral dose pharmacokinetics of alprazolam and triazolamK Otani, N Yasui, H Furukori, et al.International Clinical Psychopharmacology|January 1, 1994
Effects of mizolastine, a new antihistamine, on psychomotor performance and memory in elderly subjectsA Patat, L F Gram, C Dubruc, et al.International Clinical Psychopharmacology|January 1, 1994
A multicentre comparative trial of moclobemide, imipramine and placebo in major depressive disorder. UK Moclobemide Study GroupInternational Clinical Psychopharmacology|January 1, 1994
Chronic lithium neurotoxicity presenting as Parkinson's diseaseD Lecamwasam, B Synek, K Moyles, et al.Pageof 212